Literature DB >> 8876140

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.

M J Schnell1, L Buonocore, E Kretzschmar, E Johnson, J K Rose.   

Abstract

In a previous study we demonstrated that vesicular stomatitis virus (VSV) can be used as a vector to express a soluble protein in mammalian cells. Here we have generated VSV recombinants that express four different membrane proteins: the cellular CD4 protein, a CD4-G hybrid protein containing the ectodomain of CD4 and the transmembrane and cytoplasmic tail of the VSV glycoprotein (G), the measles virus hemagglutinin, or the measles virus fusion protein. The proteins were expressed at levels ranging from 23-62% that of VSV G protein and all were transported to the cell surface. In addition we found that all four proteins were incorporated into the membrane envelope of VSV along with the VSV G protein. The levels of incorporation of these proteins varied from 6-31% of that observed for VSV G. These results suggest that many different membrane proteins may be co-incorporated quite efficiently with VSV G protein into budding VSV virus particles and that specific signals are not required for this co-incorporation process. In fact, the CD4-G protein was incorporated with the same efficiency as wild type CD4. Electron microscopy of virions containing CD4 revealed that the CD4 molecules were dispersed throughout the virion envelope among the trimeric viral spike glycoproteins. The recombinant VSV-CD4 virus particles were about 18% longer than wild type virions, reflecting the additional length of the helical nucleocapsid containing the extra gene. Recombinant VSVs carrying foreign antigens on the surface of the virus particle may be useful for viral targeting, membrane protein purification, and for generation of immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876140      PMCID: PMC38062          DOI: 10.1073/pnas.93.21.11359

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Noninfectious vesicular stomatitis virus particles deficient in the viral nucleocapsid.

Authors:  T J Schnitzer; H F Lodish
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  D M Knipe; D Baltimore; H F Lodish
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

3.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease.

Authors:  R Cattaneo; J K Rose
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

5.  Budding of rabies virus particles in the absence of the spike glycoprotein.

Authors:  T Mebatsion; M Konig; K K Conzelmann
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

6.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes.

Authors:  L Lefrancois; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

7.  Specific incorporation of host cell surface proteins into budding vesicular stomatitis virus particles.

Authors:  H F Lodish; M Porter
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

8.  The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus.

Authors:  M J Schnell; L Buonocore; M A Whitt; J K Rose
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus.

Authors:  O N Witte; D Baltimore
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

10.  Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids.

Authors:  L D Chong; J K Rose
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more
  117 in total

1.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Rescue of mumps virus from cDNA.

Authors:  D K Clarke; M S Sidhu; J E Johnson; S A Udem
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.

Authors:  C S Robison; M A Whitt
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Polyploid measles virus with hexameric genome length.

Authors:  Monika Rager; Sompong Vongpunsawad; William Paul Duprex; Roberto Cattaneo
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

5.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

7.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope.

Authors:  E P Walsh; M D Baron; L F Rennie; P Monaghan; J Anderson; T Barrett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  Lipid rafts and pseudotyping.

Authors:  W F Pickl; F X Pimentel-Muiños; B Seed
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

10.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.